CytoMed Therapeutics Ltd

GDTC

Company Profile

  • Business description

    CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

  • Contact

    1 Commonwealth Lane
    No. 08-22 One Commonwealth
    Singapore149544
    SGP

    T: +65 62507738

    https://w2.cytomed.sg

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    42

Stocks News & Analysis

stocks

Anthropic and OpenAI face commodification threats. Here’s what to watch for

Frontier AI labs face a three-pronged set of challenges.
stocks

Berkshire Hathaway: Abel pushes into new territory with Bending Spoons investment

We think it is a sign that the firm is finally moving out of its comfort zone to find places to put capital to work.
stocks

Overlooked cheap ASX share

The market may be overlooking this share’s long-term value.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,975.7035.300.39%
CAC 407,868.0588.65-1.11%
DAX 4025,319.77302.84-1.18%
Dow JONES (US)52,059.6257.210.11%
FTSE 10010,764.69117.21-1.08%
HKSE24,186.83124.110.52%
NASDAQ26,571.34431.301.65%
Nikkei 22564,916.70407.59-0.62%
NZX 50 Index13,652.07101.66-0.74%
S&P 5007,719.9760.530.79%
S&P/ASX 2008,845.7039.000.44%
SSE Composite Index3,716.288.810.24%

Market Movers